InsightsPremium
XyloCor Therapeutics logo

XyloCor Therapeutics

0 Followers

About

XyloCor Therapeutics is a development-stage, biotechnology company dedicated to developing first-in-class gene therapies for patients with unmet medical need in cardiovascular disease.

Rickey Reinhardt
Rickey Reinhardt
Chief Medical Officer
Howard Dittrich
Howard Dittrich
SVP Research & Development
Dawn Byrnes
Dawn Byrnes
VP, Clinical Operations
Mark Peterson
Mark Peterson
Clinical Trial Manager
Jennifer Augusti
Jennifer Augusti
Operations & Finance
Michael Carson
Michael Carson
VP, Finance
Alexander Gaidamaka
Alexander Gaidamaka
SVP of Technology, Manufacturing & Quality
Rémi Gloeckler
Rémi Gloeckler
CMC

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.